Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹8114 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -0.03% | -1.31% |
6 Month | 5.1% | 6.09% |
1 Year | -2.37% | -1.17% |
3 Year | 20.44% | 22.21% |
5 Year | - | 17.82% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 1.03% | -0.13% |
1 Year | 4.35% | 4.99% |
3 Year | 18.67% | 18.87% |
5 Year | - | 17.35% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 18.94% | 16.99% |
3 Year | 20.21% | 20.8% |
5 Year | - | 20.54% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.65% | 15.22% |
Sharp | 0.78% | 0.89% |
Beta | 0.95% | 0.91% |
Alpha | -2.36% | -0.46% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.56 | 1.52 |
Large Cap | 29.45 | 33.27 |
Mid Cap | 37.33 | 33.86 |
Small Cap | 29.66 | 31.35 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.52 | 0.53 |
Healthcare | 91.78 | 99.47 |
Basic Materials | 3.67 | - |
Industrials | 1.86 | - |
Financial Services | 1.17 | - |
Top Comparisons
Kotak US Specific Equity Passive FOF - Regular Plan - Growth
3Y Returns32.75%
DSP US Flexible Equity Fund - Regular Plan - Growth
3Y Returns22.07%
Sundaram Liquid Fund (G)
3Y Returns6.95%
Canara Robeco Liquid Fund - Regular Plan - Growth Option
3Y Returns7.03%
SBI Arbitrage Opportunities Fund - Regular Plan - Gr
3Y Returns7.17%
DSP Arbitrage Fund - Regular - Growth
3Y Returns6.92%
ICICI Prudential Ultra Short Term Fund - Growth
3Y Returns7.21%
HDFC Ultra Short Term Fund - Growth Option
3Y Returns7.17%